tiprankstipranks
Trending News
More News >
Perimeter Medical Imaging Ai Inc (TSE:PINK)
:PINK
Canadian Market

Perimeter Medical Imaging AI (PINK) Earnings Dates, Call Summary & Reports

Compare
17 Followers

Earnings Data

Report Date
Jun 03, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.07
Last Year’s EPS
-0.04
Same Quarter Last Year
Moderate Buy
Based on 0 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 26, 2025
|
% Change Since: -29.31%
|
Next Earnings Date:Jun 03, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted substantial revenue growth and positive clinical trial results, along with significant progress towards FDA approval for a new product. However, high operating expenses and cash position concerns, alongside the need for additional capital, temper the positive aspects. The company is in a pivotal position with promising developments but faces typical challenges of scaling and financing.
Company Guidance
During the Perimeter Medical Q4 2024 conference call, the company provided several key metrics and guidance for the upcoming year. For the three-month period ending December 31, 2024, Perimeter Medical reported revenue of approximately $293,000, reflecting a significant 303% increase over Q4 2023. Operating expenses were approximately $4.7 million, a 6% decrease from the previous year, resulting in a net loss of $3.4 million, a 35% improvement from the $5.5 million loss in Q4 2023. Cash used in operating activities for the full year amounted to $14.7 million, consistent with 2023, with cash and cash equivalents standing at approximately $6.2 million as of year-end. The company remains focused on enhancing its financial position and is evaluating opportunities to increase cash reserves to support its growth strategy. Additionally, Perimeter Medical has submitted a premarket approval application to the FDA for its B-Series with ImgAssist AI 2.0, following positive pivotal trial results that demonstrated a statistically significant reduction in patients with residual cancer during surgery. The company anticipates potential FDA approval within a year, which would allow for the full commercial launch of the B-Series, significantly expanding its user base across the U.S. Looking ahead, Perimeter Medical expects several value inflection points in 2025, including the presentation of detailed trial results at a major conference, further contributing to its strategic growth initiatives.
Significant Revenue Growth
The company recorded revenue of $293,000 for Q4 2024, representing a 303% increase over Q4 2023.
Reduced Net Loss
The net loss for Q4 2024 was approximately $3.4 million, a 35% decrease from the $5.5 million net loss in the same period in 2023.
Positive Clinical Trial Results
The pivotal trial of the B-Series OCT with ImgAssist AI met its primary endpoint, achieving a statistically significant reduction in patients with residual cancer during surgery.
Premarket Approval Application Submission
The company submitted a premarket approval application to the FDA for the B-Series OCT with ImgAssist AI technology.
Expansion into New Markets
The company expanded into two new states, New Mexico and Tennessee, with its S-Series product.
---

Perimeter Medical Imaging AI (TSE:PINK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:PINK Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jun 03, 20252025 (Q1)
- / -
-0.03
Mar 26, 20252024 (Q4)
-0.07 / -0.06
-0.11150.00% (+0.06)
Nov 14, 20242024 (Q3)
- / -0.10
-0.014-600.00% (-0.08)
Aug 14, 20242024 (Q2)
-0.08 / -0.07
-0.11137.50% (+0.04)
May 14, 20242024 (Q1)
-0.08 / -0.04
-0.06940.00% (+0.03)
Mar 28, 20242023 (Q4)
-0.06 / -0.11
-0.062-77.78% (-0.05)
Nov 14, 20232023 (Q3)
-0.07 / -0.01
-0.011-25.00% (>-0.01)
Aug 29, 20232023 (Q2)
-0.10 / -0.11
-0.011-900.00% (-0.10)
May 25, 20232023 (Q1)
- / -
-0.085
Apr 11, 20232022 (Q4)
-0.08 / -0.07
-0.11841.18% (+0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TSE:PINK Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 26, 2025C$0.58C$0.57-1.72%
Nov 14, 2024C$0.46C$0.50+8.70%
Aug 14, 2024C$0.36C$0.360.00%
May 14, 2024C$0.58C$0.57-1.72%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Perimeter Medical Imaging Ai Inc (TSE:PINK) report earnings?
Perimeter Medical Imaging Ai Inc (TSE:PINK) is schdueled to report earning on Jun 03, 2025, TBA Not Confirmed.
    What is Perimeter Medical Imaging Ai Inc (TSE:PINK) earnings time?
    Perimeter Medical Imaging Ai Inc (TSE:PINK) earnings time is at Jun 03, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:PINK EPS forecast?
          TSE:PINK EPS forecast for the fiscal quarter 2025 (Q1) is -0.07.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis